OneChain Immunotherapeutics
Entity

  • OneChain Immunotherapeutics

    Created in 2020
  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    3,255

  • Activities

    deeptech biotech

  • Entity types

    Startup

  • Location

    Barcelona, Spain

    Barcelona

    Spain

  • Employees

    Scale: 2-10

    Estimated: 16

  • Engaged corporates

    1
    0 1

  • Added in Motherbase

    1 year, 4 months ago
Description
  • Value proposition

    Development of CAR-T candidates for the treatment of acute lymphoblastic leukemia and other hematological malignancies.

    OneChain Immunotherapeutics is a spin-off Company from the Josep Carreras Leukemia Research Institute and ICREA, that aims to develop CAR-T candidates against different antigens as a treatment for hematological malignancies based on the know-how of Dr. Pablo Menéndez.

    Biomedicina, CARTs, Inmunoterapia, Investigación, Biotecnología, Innovación, Leucemia, Hematología, and Medicina Personalizada

Corporate interactions BETA
Corporate TypeTweets Articles
EY
EY
Consulting, audit, IT Services and IT Consulting
EY
Consulting, audit, IT Services and IT Consulting 		Other

4 Aug 2023


Similar entities
Last news
Show all articles
Social network dynamics